Nanotechnology-aided advancement in the combating of cancer metastasis

Leela Rani Avula and Piotr Grodzinski

Cancer Metastasis Rev, 2022, 41, 383
DOI: 10.1007/s10555-022-10025-7

Nanotechnology-Aided Advancement in Combating the Cancer Metastasis

Arun Kumar Singh, Rishabha Malviya, Bhupendra Prajapati, Sudarshan Singh, Deepika Yadav and Arvind Kumar

Pharmaceuticals, 2023, 16, 899
DOI: 10.3390/ph16060899

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Fatih M. Uckun, Christopher R. Cogle, Tara L. Lin, Sanjive Qazi, Vuong N. Trieu, Gary Schiller and Justin M. Watts

Cancers, 2019, 12, 74
DOI: 10.3390/cancers12010074

Recent Advances in Poly(α-L-glutamic acid)-Based Nanomaterials for Drug Delivery

Yu Zhang, Wenliang Song, Yiming Lu, Yixin Xu, Changping Wang, Deng-Guang Yu and Il Kim

Biomolecules, 2022, 12, 636
DOI: 10.3390/biom12050636

Engineered nanomedicines for tumor vasculature blockade therapy

Duoyi Zhao, Xu Huang, Zhiyu Zhang, Jianxun Ding, Yan Cui and Xuesi Chen

WIREs Nanomed Nanobiotechnol, 2021, 13
DOI: 10.1002/wnan.1691

Biosynthesis of silver nanoparticles with antimicrobial and anticancer properties using two novel yeasts

Xin Liu, Jia-Le Chen, Wen-Yu Yang, Yu-Cheng Qian, Jing-Yu Pan, Chen-Nianci Zhu, Li Liu, Wen-Bin Ou, Hong-Xin Zhao and Dian-Peng Zhang

Sci Rep, 2021, 11
DOI: 10.1038/s41598-021-95262-6

Oncolytic polymer-mediated combretastatin A4 phosphate delivery for enhancing vascular disrupting therapy

Huihui Li, Kang Liu, Zexin Yang, Quanwei Sun, Wencui Shang, Yunlong Li, Mingjing Wang, Ye Yang, Hanmeng Liu, Dengke Yin and Wei Shen

International Journal of Pharmaceutics, 2025, 674, 125438
DOI: 10.1016/j.ijpharm.2025.125438

Poly(L‐Glutamic Acid)‐Drug Conjugates for Chemo‐ and Photodynamic Combination Therapy

Haiyang Yu, Yanli Bao, Caina Xu, Li Chen and Zhaohui Tang

Macromolecular Bioscience, 2021, 21
DOI: 10.1002/mabi.202000192

Polypeptides–Drug Conjugates for Anticancer Therapy

Yu Zhang, Pan He, Peng Zhang, Xuan Yi, Chunsheng Xiao and Xuesi Chen

Adv Healthcare Materials, 2021, 10
DOI: 10.1002/adhm.202001974

Combretastatin A4-combined photodynamic therapy for enhanced tumor therapeutic efficacy

Yanli Bao, Haiyang Yu, Lu Yang and Li Chen

Materials Today Communications, 2021, 28, 102616
DOI: 10.1016/j.mtcomm.2021.102616

Anti-hypoxia nanosized drug delivery systems improving cancer therapy

Wenlu Yan, Tianqun Lang, Runqi Zhu, Xiao Zhu, Yu Li, Ting Wu, Qi Yin and Yaping Li

Nano Today, 2022, 42, 101376
DOI: 10.1016/j.nantod.2022.101376

Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy

Xiaojuan Zhang, Chuanchuan He and Guangya Xiang

Cancer Letters, 2022, 530, 110
DOI: 10.1016/j.canlet.2022.01.012

Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells

Junjie Liu, Chunyu Zhu, Lihua Xu, Danyu Wang, Wei Liu, Kaixiang Zhang, Zhenzhong Zhang and Jinjin Shi

Nano Lett., 2020, 20, 8102
DOI: 10.1021/acs.nanolett.0c03042

Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect

Zhilin Liu, Yu Zhang, Na Shen, Jiali Sun, Zhaohui Tang and Xuesi Chen

Advanced Drug Delivery Reviews, 2022, 183, 114138
DOI: 10.1016/j.addr.2022.114138

Spatiotemporally Targeted Nanomedicine Overcomes Hypoxia-Induced Drug Resistance of Tumor Cells after Disrupting Neovasculature

Jinjin Chen, Zhongyu Jiang, Weiguo Xu, Tianmeng Sun, Xiuli Zhuang, Jianxun Ding and Xuesi Chen

Nano Lett., 2020, 20, 6191
DOI: 10.1021/acs.nanolett.0c02515

Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects

Huajian Zhu, Yuchen Tan, Chen He, Yang Liu, Yiping Duan, Wenjian Zhu, Tiandong Zheng, Dahong Li, Jinyi Xu, Dong-Hua Yang, Zhe-Sheng Chen and Shengtao Xu

J. Med. Chem., 2022, 65, 11187
DOI: 10.1021/acs.jmedchem.2c00681

The progress and perspective of nanoparticle-enabled tumor metastasis treatment

Wei Zhang, Fei Wang, Chuan Hu, Yang Zhou, Huile Gao and Jiang Hu

Acta Pharmaceutica Sinica B, 2020, 10, 2037
DOI: 10.1016/j.apsb.2020.07.013

Nanoparticles Composed of PEGylated Alternating Copolymer‐Combretastatin A4 Conjugate for Cancer Therapy

Yu Zhang, Xinming Liu, Xueping Wang, Pan He, Chunsheng Xiao, Haiyang Yu and Xuesi Chen

Macromolecular Bioscience, 2021, 21
DOI: 10.1002/mabi.202100077

Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy

Bahar Yetkin-Arik, Arnoud W. Kastelein, Ingeborg Klaassen, Charlotte H.J.R. Jansen, Yani P. Latul, Miloš Vittori, Aydan Biri, Korhan Kahraman, Arjan W. Griffioen, Frederic Amant, Christianne A.R. Lok, Reinier O. Schlingemann and Cornelis J.F. van Noorden

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1875, 188446
DOI: 10.1016/j.bbcan.2020.188446